News-Home

SANTA ROSA

Bankrupt startup Endomatrix sold


Published: Friday, May 9, 2008 at 3:32 a.m.
Last Modified: Friday, May 9, 2008 at 4:51 a.m.

Endomatrix Inc., a Santa Rosa startup that marketed a dietary supplement to promote cardiovascular health, has been sold in a bankruptcy proceeding.

Endomatrix developed Provasca with Actothil, a nutritional product designed to reduce inflammation of the arteries.

The active ingredient in Provasca was extracted from seaweed. The product was made for Endomatrix by a division of pharmaceutical giant Pfizer Inc.

The company, founded in 2000, had received about $6 million in private funding.

Endomatrix filed for bankruptcy in December, reporting $2.1 million in debt and $516,000 in assets. Dr. Bruce Daniels, an Oklahoma City physician and early investor in Endomatrix, acquired its assets in April for $35,000.

The company's former CEO, Glenn Foley, said Tuesday that he hasn't been involved with Endomatrix for several years.

-- Steve Hart


All rights reserved. This copyrighted material may not be re-published without permission. Links are encouraged.

Add a Comment

Only moderator-approved comments are shown on this page. To see all comments, please visit the forum. We at PressDemocrat.com created these forums as a place where our community can exchange ideas on news issues and express their thoughts. Please be courteous and respectful. Avoid expletives, false statements, veiled or overt threats and personal attacks. Stay on topic. (View full Terms of Service.)
    Post a comment | View all comments on this topic.

Next Article in Business-Home

  • CSU faculty criticizes Carinalli loans

    The association that represents California State University faculty said Thursday that the Sonoma State University Foundation “betrayed the public’s trust” by making loans to Clem Carinalli, a former board member who said he is now unable to make...